HuagongsheHuagongshe Chemistry Print Report · For research reference only
2,3,4,5-Tetrahydro-1-(1-naphthalenylcarbonyl)-1h-1,4-benzodiazepine → HCID 178478880, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2,3,4,5-Tetrahydro-1-(1-naphthalenylcarbonyl)-1h-1,4-benzodiazepine | HCID 10566283 | — |
| Reactant | 7-Bromo-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(1-naphthalenylcarbonyl)-1H-1,4-benzodiazepine, hydrochloride | HCID 178479667 | — |
| Reactant | HCID 178479669 | HCID 178479669 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 178478880 | HCID 178478880 | — |
Reaction Steps
Example 42 was prepared as an off white solid from 7-bromo-1,4-benzodiazepine (prepared as described in Compound B of Example 11) using the following procedure: Compound A of Example 4; Compound B of Example 4; Compound C of Example 4; Compound D of Example 1, using methylene chloride as solvent, purification by prep HPLC (YMC S5 ODS 30×250 mm; gradient elution with 0 to 100% buffer B over 45 min; buffer A=MeOH:H2O:TFA (10:90:0.1); buffer B=MeOH:H2O:TFA (90:10:0.1); 25 mL/min) and conversion to the HCl salt by lyophilization from 1M HCl.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06011029 |
| Source dataset | uspto-grants-2000_01 |
| ORD ID | ord-c987e10a173f4e0e9a851a42ceb04421 |
| Source note | uspto-grants-2000_01 |